Cargando…

Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience

Reconstructive surgery following skin tumor resection can be challenging. Treatment options after removing the tumor are skin grafting, local pedicled and axial flaps, or microsurgery for complex and extensive wounds correction. Recently, the use of dermal substitutes has been extended to reconstruc...

Descripción completa

Detalles Bibliográficos
Autores principales: Campagnari, Mariane, Jafelicci, Andrea S., Carneiro, Helio A., Brechtbühl, Eduard R., Bertolli, Eduardo, Duprat Neto, João P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511644/
https://www.ncbi.nlm.nih.gov/pubmed/28751990
http://dx.doi.org/10.1155/2017/9805980
_version_ 1783250373473992704
author Campagnari, Mariane
Jafelicci, Andrea S.
Carneiro, Helio A.
Brechtbühl, Eduard R.
Bertolli, Eduardo
Duprat Neto, João P.
author_facet Campagnari, Mariane
Jafelicci, Andrea S.
Carneiro, Helio A.
Brechtbühl, Eduard R.
Bertolli, Eduardo
Duprat Neto, João P.
author_sort Campagnari, Mariane
collection PubMed
description Reconstructive surgery following skin tumor resection can be challenging. Treatment options after removing the tumor are skin grafting, local pedicled and axial flaps, or microsurgery for complex and extensive wounds correction. Recently, the use of dermal substitutes has been extended to reconstructive surgery in cutaneous oncology. Objectives. To report both a single-center experience using dermal substitutes in reconstructive surgery for skin malignancies and reconstructive surgery's outcomes. Methods and Results. Among thirteen patients, seven (53.8%) were male with mean age of 62.6 years. Regarding diagnosis, there were five cases (38.5%) of basal cell carcinoma (BCC), two (15.4%) of melanoma in situ, two (15.4%) of dermatofibrosarcoma protuberans, one (7.7%) of squamous cell carcinoma (SCC), one (7.7%) of angiosarcoma, and one (7.7%) of eccrine carcinoma (EC). The most common site of injury was scalp (53.8%) and lower limbs (23.1%). Seven (53.8%) patients used NPWT and six (46.2%) patients underwent Brown's dressing. The most frequent complication of the first stage was wound contamination (38.5%). Average time to second-stage skin grafting was 43.9 days. Three (23%) patients developed tumor recurrence and one died. Conclusions. Use of dermal substitutes in oncology can be an option for reconstruction after extended resections, providing good aesthetical and functional results.
format Online
Article
Text
id pubmed-5511644
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-55116442017-07-27 Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience Campagnari, Mariane Jafelicci, Andrea S. Carneiro, Helio A. Brechtbühl, Eduard R. Bertolli, Eduardo Duprat Neto, João P. Int J Surg Oncol Research Article Reconstructive surgery following skin tumor resection can be challenging. Treatment options after removing the tumor are skin grafting, local pedicled and axial flaps, or microsurgery for complex and extensive wounds correction. Recently, the use of dermal substitutes has been extended to reconstructive surgery in cutaneous oncology. Objectives. To report both a single-center experience using dermal substitutes in reconstructive surgery for skin malignancies and reconstructive surgery's outcomes. Methods and Results. Among thirteen patients, seven (53.8%) were male with mean age of 62.6 years. Regarding diagnosis, there were five cases (38.5%) of basal cell carcinoma (BCC), two (15.4%) of melanoma in situ, two (15.4%) of dermatofibrosarcoma protuberans, one (7.7%) of squamous cell carcinoma (SCC), one (7.7%) of angiosarcoma, and one (7.7%) of eccrine carcinoma (EC). The most common site of injury was scalp (53.8%) and lower limbs (23.1%). Seven (53.8%) patients used NPWT and six (46.2%) patients underwent Brown's dressing. The most frequent complication of the first stage was wound contamination (38.5%). Average time to second-stage skin grafting was 43.9 days. Three (23%) patients developed tumor recurrence and one died. Conclusions. Use of dermal substitutes in oncology can be an option for reconstruction after extended resections, providing good aesthetical and functional results. Hindawi 2017 2017-07-02 /pmc/articles/PMC5511644/ /pubmed/28751990 http://dx.doi.org/10.1155/2017/9805980 Text en Copyright © 2017 Mariane Campagnari et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Campagnari, Mariane
Jafelicci, Andrea S.
Carneiro, Helio A.
Brechtbühl, Eduard R.
Bertolli, Eduardo
Duprat Neto, João P.
Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience
title Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience
title_full Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience
title_fullStr Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience
title_full_unstemmed Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience
title_short Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience
title_sort dermal substitutes use in reconstructive surgery for skin tumors: a single-center experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511644/
https://www.ncbi.nlm.nih.gov/pubmed/28751990
http://dx.doi.org/10.1155/2017/9805980
work_keys_str_mv AT campagnarimariane dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience
AT jafelicciandreas dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience
AT carneirohelioa dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience
AT brechtbuhleduardr dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience
AT bertollieduardo dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience
AT dupratnetojoaop dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience